We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

128 hedge funds and large institutions have $456M invested in Filana Therapeutics in 2021 Q1 according to their latest regulatory filings, with 60 funds opening new positions, 34 increasing their positions, 29 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

590% more capital invested

Capital invested by funds: $66.1M → $456M (+$390M)

445% more first-time investments, than exits

New positions opened: 60 | Existing positions closed: 11

62% more funds holding

Funds holding: 79 → 128 (+49)

61% more call options, than puts

Call options by funds: $83.5M | Put options by funds: $51.8M

17% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 29

2.13% less ownership

Funds ownership: 28.79% → 26.66% (-2.1%)

Holders
128
Holders Change
+49
Holders Change %
+62.03%
% of All Funds
2.25%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
60
Increased
34
Reduced
29
Closed
11
Calls
$83.5M
Puts
$51.8M
Net Calls
+$31.7M
Net Calls Change
+$32.9M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$17.1M
2
Group One Trading
Group One Trading
Illinois
+$14.1M
3
MWNA
Marshall Wace North America
New York
+$11.1M
4
State Street
State Street
Massachusetts
+$9.35M
5
Millennium Management
Millennium Management
New York
+$9.01M

Top Sellers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
-$8.33M
2
FMBTD
First Midwest Bank Trust Division
Illinois
-$5.28M
3
N
Nuveen
North Carolina
-$5.27M
4
Wells Fargo
Wells Fargo
California
-$5.14M
5
CCM
CAAS Capital Management
New York
-$4.69M
Name Holding Trade Value Shares
Change 		Change in
Stake
DCM
126
DAFNA Capital Management
California
– -$3.07M -450,000 Closed
CM
127
CM Management
Florida
– -$1.19M -175,000 Closed
ECM
128
ExodusPoint Capital Management
New York
– -$521K -76,437 Closed
JF
129
Jump Financial
Illinois
– -$438K -64,282 Closed
SC
130
Sculptor Capital
New York
– -$207K -30,300 Closed
IC
131
Intersect Capital
California
– -$136K -20,000 Closed
GCP
132
GSA Capital Partners
United Kingdom
– -$127K -18,646 Closed
SFI
133
Susquehanna Fundamental Investments
Pennsylvania
– -$116K -17,044 Closed
QT
134
Quantbot Technologies
New York
– -$34K -5,007 Closed
LSA
135
Leonteq Securities AG
Switzerland
– -$34.1K -5,000 Closed
CAPTRUST Financial Advisors
136
CAPTRUST Financial Advisors
North Carolina
– +$157 +4 New
HR
137
Howe & Rusling
New York
– +$236 +6 New
PA
138
Parallel Advisors
California
– +$393 +10 New
WAP
139
Wealthcare Advisory Partners
Pennsylvania
– +$393 +10 New
2 3 4 5
6

FLNA Hedge Fund Activity: Q1 2021 in Review

128 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q1 2021, worth a combined $456M — up 590% from $66.1M a quarter earlier.

Buyers outnumbered sellers: 60 funds opened new FLNA positions and 11 closed out — a net gain of 49 holders — while 34 added to existing stakes and 29 trimmed.

The largest buyer was BlackRock, adding an estimated $17.1M. The largest seller was Marshall Wace, cutting an estimated $8.33M.

  • 128 institutional investors held Filana Therapeutics (FLNA) as of Q1 2021, up from 79 in Q4 2020.
  • Funds reported $456M of Filana Therapeutics stock for Q1 2021, up 590% quarter-over-quarter.
  • 60 funds opened new Filana Therapeutics positions in Q1 2021 and 11 closed out, a net change of +49 holders.
  • The largest Filana Therapeutics buyer in Q1 2021 was BlackRock, an estimated $17.1M added.
  • The largest Filana Therapeutics seller in Q1 2021 was Marshall Wace, an estimated $8.33M sold.

Based on aggregated 13F filings for Q1 2021.